Key result
Administrative open access policy directive contains no clinical research data.
Why the study?
HFpEF diagnosis is challenging and imprecise because of the lack of a single diagnostic marker, the limitations of echocardiography, and the limitations of LVEF as a marker of LV function.
Does cardiac magnetic resonance provide superior diagnostic precision compared to echocardiography in patients with HFpEF?
Does cardiac magnetic resonance provide superior diagnostic precision compared to echocardiography in patients with HFpEF?
Cardiac magnetic resonance offers superior diagnostic precision and tissue characterization for HFpEF compared to standard echocardiography.
No clinical research data present; leaves open whether CMR offers superior diagnostic precision over echocardiography in HFpEF.
Heart failure with preserved ejection fraction (HFpEF) burden is increasing. Its diagnostic process is challenging and imprecise due to absence of a single diagnostic marker, and the multiparametric echocardiography evaluation needed. Left ventricular (LV) ejection fraction (LVEF) is a limited marker of LV function; thus, allocating HF phenotypes based on LVEF can be misleading. HFpEF encompasses a broad spectrum of causes, and its diagnostic criteria give a central role to echocardiography, a first-line technique with inherent limitations related to ultrasound capabilities. Conversely, cardiac magnetic resonance provides superior anatomic and functional assessment, enabling tissue characterization, offering unprecedented diagnostic precision.
No takes yet. Share an insight, caveat, or question.
Vega et al. (2021) studied this question. The provided text is an administrative open access policy directive for Çanakkale Onsekiz Mart University and contains no clinical research data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: